TORONTO, ON--(Marketwired - September 26, 2016) - The presentation will focus on managing evidence including market access and reimbursement challenges around cell and gene therapies to enhance market adoption.
The live broadcast hosted by Xtalks on Friday, October 14, 2016 features David Pruce, Principal, Pricing & Market Access at ICON as the featured speaker. Attendees will gain valuable insights on:
- How payers are reacting to emerging cell and gene therapies
- How to address payers evidence concerns
- The types of agreements that payers will want in order to facilitate market access
- How market access solutions vary across countries
The emergence and rise of gene and cell therapies has the potential to significantly change the way we manage and treat disease. While payers recognize that gene and cell therapies are likely to be the next big step in the evolution of medicine, the upfront costs of treatment and the uncertainty over long-term outcomes will present major pricing and market access hurdles. Individual therapies can be challenging for payers to fund but the potential for dozens of high cost cell and gene therapies would significantly impact already constrained budgets.
How will payers assess such innovative therapies which still have to prove their duration of efficacy? How do manufacturers price a drug that has the potential to cure, or confer lifelong benefit from a single administration? How will already financially stretched healthcare authorities fund patient access to these therapies?
The lack of certainty between the data at launch and the ongoing clinical performance expectations top the list of clinical and reimbursement concerns for both HTA reviewers and the payers they influence. Short follow up time and low numbers of patients contribute to this uncertainty as do the nature of the single arm studies which tend to overestimate the benefits.
To learn more about this complimentary event visit: Market Access Hurdles for Cell and Gene Therapies: Managing Evidence to Enhance Market Adoption.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2016/9/23/11G115452/Images/ICON_logo_200-830120556669.jpg